Sansure Biotech Inc (688289) — Cash Flow Quality Index
Sansure Biotech Inc (688289) has a Cash Flow Quality Index of 2.09x as of September 2025. Operating cash flow of CN¥59.72 Million exceeds net income of CN¥28.60 Million, indicating high earnings quality where cash backs reported profits. Explore 688289 cash flow conversion to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Sansure Biotech Inc Cash Flow Quality Index (2018–2025)
Historical Cash Flow Quality Index for Sansure Biotech Inc across 8 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check 688289 capex plus investments ratio to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for Sansure Biotech Inc (2018–2025)
Year-by-year earnings quality comparison for Sansure Biotech Inc. For live market cap and the full company financial profile, see market value of Sansure Biotech Inc.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 0.93x | CN¥183.96 Million | CN¥198.15 Million | ▼ -23.5% |
| 2024 | 1.21x | CN¥274.45 Million | CN¥226.27 Million | ▲ +274.3% |
| 2023 | 0.32x | CN¥112.82 Million | CN¥348.17 Million | ▼ -75.5% |
| 2022 | 1.32x | CN¥2.56 Billion | CN¥1.94 Billion | ▲ +57.9% |
| 2021 | 0.84x | CN¥1.88 Billion | CN¥2.24 Billion | ▼ -17.1% |
| 2020 | 1.01x | CN¥2.64 Billion | CN¥2.62 Billion | ▲ +77.9% |
| 2019 | 0.57x | CN¥22.41 Million | CN¥39.48 Million | ▼ -61.9% |
| 2018 | 1.49x | CN¥10.07 Million | CN¥6.76 Million | — |